 Community Pharmacy Services
"Community Pharmacy Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Total pharmaceutical services provided to the public through community pharmacies.
| Descriptor ID |
D003157
|
| MeSH Number(s) |
N02.421.143.221 N02.421.668.274
|
| Concept/Terms |
Community Pharmacy Services- Community Pharmacy Services
- Service, Community Pharmacy
- Services, Community Pharmaceutic
- Services, Community Pharmaceutical
- Services, Community Pharmacy
- Service, Community Pharmaceutic
- Community Pharmaceutical Services
- Community Pharmaceutical Service
- Pharmaceutic Services, Community
- Pharmaceutical Service, Community
- Pharmaceutical Services, Community
- Pharmacy Services, Community
- Community Pharmacy Service
- Pharmacy Service, Community
- Service, Community Pharmaceutical
- Community Pharmaceutic Services
- Community Pharmaceutic Service
- Pharmaceutic Service, Community
|
Below are MeSH descriptors whose meaning is more general than "Community Pharmacy Services".
Below are MeSH descriptors whose meaning is more specific than "Community Pharmacy Services".
This graph shows the total number of publications written about "Community Pharmacy Services" by people in UAMS Profiles by year, and whether "Community Pharmacy Services" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 | | 2023 | 2 | 0 | 2 | | 2022 | 8 | 0 | 8 | | 2020 | 5 | 1 | 6 | | 2019 | 4 | 0 | 4 | | 2018 | 1 | 2 | 3 | | 2017 | 5 | 0 | 5 | | 2016 | 1 | 1 | 2 | | 2015 | 4 | 0 | 4 | | 2014 | 5 | 1 | 6 | | 2013 | 2 | 0 | 2 | | 2010 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2005 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Community Pharmacy Services" by people in Profiles over the past ten years.
-
Appolon G, Tang S, Gabriel N, Morales J, Berenbrok LA, LaCroix AZ, Guo J, Mathis WS, Hernandez I. Racial and ethnic inequities in spatial access to pharmacies: A?geographic information system analysis. J Am Pharm Assoc (2003). 2024 Jul-Aug; 64(4):102131.
-
Smith MG, Abdullah E. Expanding scope: Impact and preferred implementation strategies for statewide test and treat protocols. J Am Pharm Assoc (2003). 2023 Sep-Oct; 63(5):1617-1622.
-
Carpenter D, Mashburn P, Hastings T, Westrick S, Rosenthal M, Smith M, Kiser S, Curran G. RURAL-CP: a rural community pharmacy practice-based research network in the USA. Rural Remote Health. 2023 01; 23(1):8092.
-
Gamble A, Hastings TJ, Westrick SC, Smith M, Hannings AN, Robinson JM, Rosenthal M, Kiser SN, Curran G, Carpenter DM. COVID-19 booster vaccination in rural community pharmacies. Vaccine. 2023 01 27; 41(5):999-1002.
-
Nichols MA, Kepley KL, Rosko KS, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Community pharmacist-provided opioid intervention frequencies and barriers. J Am Pharm Assoc (2003). 2023 Jan-Feb; 63(1):336-342.
-
Hohmann LA, Fox BI, Garza KB, Wang CH, Correia C, Curran GM, Westrick SC. Impact of a Multicomponent Educational Intervention on Community Pharmacy-Based Naloxone Services Implementation: A Pragmatic Randomized Controlled Trial. Ann Pharmacother. 2023 06; 57(6):677-695.
-
Doucette WR, Bacci JL, Coley KC, Daly CJ, Ferreri SP, McDonough RP, McGivney MAS, Smith MG. A taxonomy for community pharmacy patient care services reported in Pharmacist eCare Plans. J Am Pharm Assoc (2003). 2023 Jan-Feb; 63(1):173-177.
-
Little MA, Porter KJ, Pebley K, Wiseman KP, Cohn W, Anderson RT, Krukowski RA. Evaluating the feasibility of pharmacist-facilitated tobacco cessation interventions in independent community pharmacies in rural Appalachia. J Am Pharm Assoc (2003). 2022 Nov-Dec; 62(6):1807-1815.
-
Murphy PZ, Jester AP. Pharmacists' Knowledge and Perceptions of Health Literacy. J Pharm Pract. 2023 Jun; 36(3):620-627.
-
Carpenter DM, Hastings T, Westrick S, Mashburn P, Rosenthal M, Smith M, Kiser S, Gamble A, Brewer NT, Curran G. Rural community pharmacists' ability and interest in administering COVID-19 vaccines in the Southern United States. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1379-1383.
-
Smith MG, Nuffer W, O'Connor S. Redefining 'advanced': Supporting and promoting practice change through community advanced pharmacy practice experiences. Curr Pharm Teach Learn. 2022 02; 14(2):133-137.
-
Carpenter DM, Hastings T, Westrick S, Rosenthal M, Mashburn P, Kiser S, Shepherd JG, Curran G. Rural community pharmacies' preparedness for and responses to COVID-19. Res Social Adm Pharm. 2021 07; 17(7):1327-1331.
-
Teeter BS, Thomas JL, Curran GM, Balamurugan A. Classifying intervention modifications in the community pharmacy context: A demonstration study. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):e230-e235.
-
Adunlin G, Murphy PZ, Manis M. COVID-19: How Can Rural Community Pharmacies Respond to the Outbreak? J Rural Health. 2021 01; 37(1):153-155.
-
Smith MG, Rains L. Evaluation of an accredited training program on implementation of point-of-care testing in community pharmacies. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):e140-e144.
-
Snyder ME, Chewning B, Kreling D, Perkins SM, Knox LM, Adeoye-Olatunde OA, Jaynes HA, Schommer JC, Murawski MM, Sangasubana N, Hillman LA, Curran GM. An evaluation of the spread and scale of PatientToc? from primary care to community pharmacy practice for the collection of patient-reported outcomes: A study protocol. Res Social Adm Pharm. 2021 02; 17(2):466-474.
-
Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460.
-
Stafford RA, Garrett LN, Bates KA, Diemer TB, Thomas JL, Smith MG, Teeter BS, Curran GM. Development and implementation of a collaboration between a patient-centered medical home and community pharmacy. J Am Pharm Assoc (2003). 2020 Jan - Feb; 60(1):122-129.
-
Klepser DG, Klepser ME, Murry JS, Borden H, Olsen KM. Evaluation of a community pharmacy-based influenza and group A streptococcal pharyngitis disease management program using polymerase chain reaction point-of-care testing. J Am Pharm Assoc (2003). 2019 Nov - Dec; 59(6):872-879.
-
Burnside TPT, Scott NJ, Smith MG. Implementation of technician-driven medication therapy management program in community pharmacies. J Am Pharm Assoc (2003). 2019 Jul - Aug; 59(4S):S156-S160.e2.
-
Teeter BS, Mosley C, Thomas JL, Martin B, Jones D, Romero JR, Curran GM. Improving HPV vaccination using implementation strategies in community pharmacies: Pilot study protocol. Res Social Adm Pharm. 2020 03; 16(3):336-341.
-
Bowers BL, Rowe JM, Stafford RA. Using an Algorithm to Assess Vaccination Among Patients Who Attended a Pharmacy Student-Driven Statewide Free Health Screening. J Pharm Pract. 2020 Aug; 33(4):425-432.
-
Moore LD, Smith MG. Positive Impact of Technician-Driven MTM Program on Performance Measures. J Pharm Pract. 2020 Jun; 33(3):283-286.
-
Painter JT, Gressler L, Kathe N, Slabaugh SL, Blumenschein K. Consumer willingness to pay for pharmacy services: An updated review of the literature. Res Social Adm Pharm. 2018 12; 14(12):1091-1105.
-
Gubbins PO, Klepser ME, Adams AJ, Jacobs DM, Percival KM, Tallman GB. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases. J Public Health Manag Pract. 2017 Nov/Dec; 23(6):593-600.
-
Shoemaker SJ, Curran GM, Swan H, Teeter BS, Thomas J. Application of the Consolidated Framework for Implementation Research to community pharmacy: A framework for implementation research on pharmacy services. Res Social Adm Pharm. 2017 Sep - Oct; 13(5):905-913.
-
Pezzino NC, Marciniak MW, Smith MG, Ferreri SP. Physician-reported factors that encourage collaboration with community pharmacists. J Am Pharm Assoc (2003). 2017 May - Jun; 57(3S):S279-S283.e2.
-
Smith MG, Shea CM, Brown P, Wines K, Farley JF, Ferreri SP. Pharmacy characteristics associated with the provision of medication management services within an integrated care management program. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2):217-221.e1.
-
Smith MG, Ferreri SP, Brown P, Wines K, Shea CM, Pfeiffenberger TM. Implementing an integrated care management program in community pharmacies: A focus on medication management services. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2):229-235.e1.
-
Teeter BS, Fox BI, Garza KB, Harris SG, Nau DP, Owensby JK, Westrick SC. Community pharmacy owners' views of star ratings and performance measurement: In-depth interviews. J Am Pharm Assoc (2003). 2016 Sep-Oct; 56(5):549-54.
-
Dayer L, Dunn E, Pace A, Flowers S. Pharmacists' perceived knowledge of and confidence in dispensing oral antineoplastic agents. J Am Pharm Assoc (2003). 2016 Mar-Apr; 56(2):141-4.e2.
-
Hinds A, Coulter L, Hudson J, Seaton V. Screening for diabetes in patients receiving second-generation atypical antipsychotics. Am J Health Syst Pharm. 2015 Sep 01; 72(17 Suppl 2):S70-3.
-
Smith MG, Ferreri SP. A model to inform community pharmacy's collaboration in outpatient care. Res Social Adm Pharm. 2016 May-Jun; 12(3):529-34.
-
Barnoya J, Jin L, Hudmon KS, Schootman M. Nicotine replacement therapy, tobacco products, and electronic cigarettes in pharmacies in St. Louis, Missouri. J Am Pharm Assoc (2003). 2015 Jul-Aug; 55(4):405-12.
-
Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. Developing a framework of care for opioid medication misuse in community pharmacy. Res Social Adm Pharm. 2016 Mar-Apr; 12(2):293-301.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|